Molecular Diagnostic / RT-PCR Control Set Cobas® Liat® SARS-CoV-2 and Influenza A / B Positive Level / Negative Level 3 X 0.25 mL / 3 X 10 µL / 3 X 0.3 mL

Features

• cobas® SARS-CoV-2 & Influenza A/B nucleic acid test for use on the cobas® liat analyzer has successfully completed its transition from Emergency Use Authorization (EUA) product to 510(k) cleared product
• The new cobas SARS-CoV-2 & Influenza A/B test analyzes nucleic acids from nasopharyngeal and nasal swab samples and self-collected nasal swabs (collected in a healthcare setting with instruction by a healthcare provider) to enable frontline healthcare workers to quickly identify and differentiate these similarly presenting infections
• This test has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A virus, and influenza B virus and not for any other viruses or pathogens
• cobas® SARS-CoV-2 & Influenza A/B is intended for use by health professionals or trained operators who are proficient in using the cobas® Liat System
• Includes: 11 Transfer Pipettes and 1 Control Kit Barcode Card
• 3 X 0.25 mL SARS-Cov-2 (+), 3 X 10 µL FLU A/B (+), 3 X 0.3 mL Dilution UTM (-)

More Information

• cobas Liat SARS-CoV-2 + Flu A+B 510k Clearance Customer Bulletin
• cobas SARS-CoV-2 + Flu A+B CLIA Waived IFU
• SDS